Source: Markets Insider

Sagent Pharmaceuticals: Sagent Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Levetiracetam Injection, USP Due to Lack of Sterility Assurance

CHICAGO, Nov. 19, 2021 /PRNewswire/ -- Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of four lots of Levetiracetam ...

Read full article »
Sagent Pharmaceuticals's Competitors | Sagent Pharmaceuticals's News | Sagent Pharmaceuticals's Financials
Stay up-to-date with the latest news on Sagent
Est. Annual Revenue
$100-500M
Est. Employees
250-500
Peter Kaemmerer's photo - CEO of Sagent

CEO

Peter Kaemmerer

CEO Approval Rating

68/100

Read more
Stay up-to-date with the latest news on Sagent